Michael Carusi
SlowingNamed in filings at Lightstone VenturesOn the current fund
- Board seats filed
- 12
Named in filings at Lightstone VenturesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Apreo Health | Medical devices | August 2025 | None on file |
| SHOULDER INNOVATIONS | Medical devices | October 2020 | U.S Venture Partners |
| Tallac Therapeutics | Biotech & pharma | June 2020 | Venbio Global Strategic |
| MediSix Therapeutics | Biotech & pharma | September 2019 | Osage University Partners, OUP |
| Foundry Therapeutics 1 | Biotech & pharma | January 2019 | NEA |
| CALA HEALTH | Medical devices | January 2016 | None on file |
| ExploraMed NC7 | Medical devices | January 2015 | NEA |
| NUVAIRA | Medical devices | April 2014 | U.S Venture Partners |
| ENDOGASTRIC SOLUTIONS | Not yet classified | April 2014 | None on file |
| PowerVision | Enterprise software | January 2014 | Aisling Capital |
| GYNESONICS | Digital health | February 2013 | Abingworth Bioventures, Bain Capital Life Sciences |
| GLUMETRICS | Medical devices | March 2012 | Versant Venture Capital |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Michael Carusi on the board, based on 11 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.